Cytosorbents Corp
CTSO
51 hedge funds and large institutions have $14.1M invested in Cytosorbents Corp in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 12 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 10
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
2.34% less ownership
Funds ownership: 30.3% → 27.96% (-2.3%)
4% less funds holding
Funds holding: 53 → 51 (-2)
43% less capital invested
Capital invested by funds: $24.7M → $14.1M (-$10.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$140K |
| 2 |
AC
Avenir Corporation
Alexandria,
Virginia
|
+$116K |
| 3 |
EGM
Engineers Gate Manager
New York
|
+$51.8K |
| 4 |
CCC
Cable Car Capital
San Francisco,
California
|
+$49.1K |
| 5 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$41K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$874K |
| 2 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
-$370K |
| 3 |
AE
AMH Equity
Great Neck,
New York
|
-$124K |
| 4 |
NAS
NWF Advisory Services
Los Angeles,
California
|
-$100K |
| 5 |
CM
CM Management
Gulf Breeze,
Florida
|
-$98.1K |
CTSO Hedge Fund Activity: Q4 2024 in Review
51 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q4 2024, worth a combined $14.1M — down 43% from $24.7M a quarter earlier.
Fund positioning in CTSO was balanced in Q4 2024: 12 funds opened new positions, 12 closed out, 14 added to existing stakes and 10 trimmed.
The largest buyer was UBS Group, adding an estimated $140K. The largest seller was Granahan Investment Management, cutting an estimated $874K.
- 51 institutional investors held Cytosorbents Corp (CTSO) as of Q4 2024, down from 53 in Q3 2024.
- Funds reported $14.1M of Cytosorbents Corp stock for Q4 2024, down 43% quarter-over-quarter.
- 12 funds opened new Cytosorbents Corp positions in Q4 2024 and 12 closed out, a net change of 0 holders.
- The largest Cytosorbents Corp buyer in Q4 2024 was UBS Group, an estimated $140K added.
- The largest Cytosorbents Corp seller in Q4 2024 was Granahan Investment Management, an estimated $874K sold.
Based on aggregated 13F filings for Q4 2024.